FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nutra Pharma's Free Cash Flow for the
three
months ended in Sep. 2022 was $-0.17 Mil. Nutra Pharma's Revenue for the
three
months ended in Sep. 2022 was $0.11 Mil. Therefore, Nutra Pharma's FCF Margin % for the quarter that ended in Sep. 2022 was -151.38%.
The historical rank and industry rank for Nutra Pharma's FCF Margin % or its related term are showing as below:
NPHC'
s FCF Margin % Range Over the Past 10 Years
Min: -406.48 Med: 0 Max: 0
Current: -406.48
NPHC's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.2
vs NPHC: -406.48
Nutra Pharma FCF Margin % Historical Data
The historical data trend for Nutra Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nutra Pharma's FCF Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Nutra Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutra Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nutra Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nutra Pharma's FCF Margin % falls into.
Nutra Pharma FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Nutra Pharma's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutra Pharma FCF Margin % Related Terms
Thank you for viewing the detailed overview of Nutra Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nutra Pharma Corp operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. It also develops proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Some of its drug names are Cobroxin, Nyloxin, RPI-78M, RPI-MN and Pet Pain-Away.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NPHC has been successfully added to your 